Analyst Consensus ?
ConsensusBuy59 ratings
Bullish3355.9%
Neutral2644.1%
Bearish00.0%
1 unmapped firm rating excluded from the percentages.
Fiserv, Inc. · FISV · FY2025 Q1 · Calendar Q2 2025
Fiserv keeps FY2025 guidance as Clover and acquisitions drive expansion
The supplied analysis supports a constructive but conditional view: Fiserv's growth initiatives and maintained guidance provide evidence of resilience, while Clover monetization, acquisition execution, processing trends, and international margin expansion remain unproven.
Reported Before market openNASDAQTechnology
$25.10B market cap
85quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$2.47
Consensus $2.43
EPS surprise
+1.6%
Reported versus consensus
Reported revenue
$5.52B
Consensus $5.19B
Revenue surprise
+6.2%
Reported versus consensus
Market reaction
unavailable
Stock move
—
Event window
SPY move
—
Same window
Abnormal move
—
Stock minus SPY
Volume
—
Versus trailing sessions
Subsequent drift
—
Up to 20 sessions
Price and volume data were unavailable at publication time.
Ask FN2 about FISV FY2025 Q1
Transcript, numbers and history already loaded
How did the market react to FISV FY2025 Q1 earnings, and why?What changed in FISV's guidance and outlook in FY2025 Q1?Give me the bull and bear case for FISV after FY2025 Q1 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior analysis, Fiserv reported Q1 organic growth of 7%, 14% adjusted EPS growth, 27% Clover revenue growth, expansion to 13 countries, and four strategic acquisitions. Guidance remained maintained, while the analysis added focus on processing weakness, Canada-related softness, and acquisition integration.
Guidance delta
Management maintained FY2025 guidance of 10–12% organic revenue growth and $10.1–$10.3 adjusted EPS, unchanged from the prior analysis.
Key takeaways
- Q1 organic revenue grew 7%, adjusted EPS rose 14%, and operating margin expanded 200 basis points.
- Clover revenue grew 27% and expanded to 13 countries, while four acquisitions broadened international and embedded-finance capabilities.
- The central question is whether Clover volume growth, acquisitions, and new products convert into durable revenue growth.
Management priorities
- Expand Clover into new geographies and product lines, including Hospitality.
- Integrate Cash Flow Central with Clover and broaden adoption.
- Use embedded finance, AI-driven tools, and additional acquisitions to extend the platform.
Follow FISV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$47.61Current
$46Low
$126.31Average
$244High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 16, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Hold | Hold | Maintain | Oct 9, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Oct 9, 2026 |
| Oppenheimer | Perform | Outperform | Downgrade | Oct 8, 2026 |
| B. Riley Securities | Neutral | Neutral | Maintain | Sep 28, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Aug 31, 2026 |
| Truist Securities | Hold | Hold | Maintain | Aug 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 7, 2026 |
| Susquehanna | Positive | Positive | Maintain | Aug 7, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Aug 7, 2026 |
| Keefe, Bruyette & Woods | Outperform | Outperform | Maintain | Aug 7, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 7, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jul 22, 2026 |
| Citigroup | Neutral | Neutral | Maintain | Jul 10, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Jul 9, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Jul 9, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | May 29, 2026 |
| Mizuho | Outperform | Outperform | Maintain | May 6, 2026 |
| Raymond James | Market Perform | Outperform | Downgrade | Mar 26, 2026 |
| Tigress Financial | Buy | Buy | Maintain | Mar 11, 2026 |
| Stephens & Co. | Equal Weight | Equal Weight | Maintain | Feb 11, 2026 |
| Seaport Global | Neutral | Buy | Downgrade | Oct 30, 2025 |
| Keybanc | Overweight | Downgrade | Oct 30, 2025 | |
| Bernstein | Market Perform | Outperform | Downgrade | Oct 30, 2025 |
| Argus Research | Hold | Buy | Downgrade | Oct 30, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Oct 29, 2025 |
| BTIG | Buy | Buy | Maintain | Oct 29, 2025 |
| Baird | Outperform | Outperform | Maintain | Jul 24, 2025 |
| Jefferies | Hold | Hold | Maintain | May 27, 2025 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 26, 2023 |
| Atlantic Equities | Neutral | Overweight | Downgrade | Oct 11, 2022 |
| Evercore ISI Group | Outperform | In Line | Upgrade | Aug 10, 2022 |
| Loop Capital | Buy | Buy | Maintain | May 3, 2022 |
| Rosenblatt | Buy | Buy | Maintain | Apr 27, 2022 |
| Cowen & Co. | Perform | Outperform | Downgrade | Apr 12, 2022 |
| Wedbush | Outperform | Outperform | Maintain | Dec 19, 2021 |
| B of A Securities | Buy | Buy | Maintain | Dec 16, 2021 |
| Edward Jones | Buy | Hold | Upgrade | Dec 15, 2021 |
| Exane BNP Paribas | Neutral | Underperform | Upgrade | Aug 9, 2021 |
| Compass Point | Buy | Buy | Maintain | Sep 17, 2020 |
| Keefe Bruyette & Woods | Outperform | Outperform | Maintain | May 8, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | May 7, 2020 |
| Deutsche Bank | Buy | Buy | Maintain | May 7, 2020 |
| CFRA | Buy | Buy | Maintain | May 7, 2020 |
| Canaccord Genuity | Buy | Buy | Maintain | Sep 12, 2019 |
| Berenberg | Buy | Buy | Maintain | Jul 31, 2019 |
| Tudor Pickering | Buy | Hold | Upgrade | Jul 2, 2019 |
| Northcoast Research | Buy | Neutral | Upgrade | Jun 25, 2019 |
| Northcoast | Buy | Neutral | Upgrade | Jun 25, 2019 |
| Buckingham | Buy | Buy | Maintain | Feb 7, 2019 |
| William Blair | Outperform | Market Perform | Upgrade | Jan 21, 2019 |
| Argus | Buy | Buy | Maintain | Sep 19, 2018 |
| Guggenheim | Buy | Neutral | Upgrade | Jul 16, 2017 |
| Pacific Crest | Equal Weight | Sector Weight | Maintain | Nov 18, 2016 |
| Monness Crespi Hardt | Buy | Neutral | Upgrade | Oct 4, 2016 |
| Monness, Crespi, Hardt | Buy | Neutral | Upgrade | Oct 3, 2016 |
| Sterne Agee CRT | Buy | Buy | Maintain | Dec 17, 2015 |
| FBR Capital | Market Perform | Outperform | Downgrade | Dec 5, 2014 |
| Sterne Agee | Buy | Neutral | Upgrade | Aug 6, 2013 |
| First Analysis | Overweight | Equal Weight | Upgrade | Aug 5, 2013 |
| DA Davidson | Neutral | Buy | Downgrade | May 1, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $47.61. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $50 | $45.94 | +5.0% | Oct 9, 2026 |
| Truist Financial | Matthew Coad | $53 | $51.5 | +11.3% | Aug 20, 2026 |
| Goldman Sachs | Will Nance | $54 | $52.01 | +13.4% | Aug 7, 2026 |
| Morgan Stanley | James Faucette | $59 | $51.94 | +23.9% | Aug 7, 2026 |
| UBS | Analyst unavailable | $60 | $51.96 | +26.0% | Aug 7, 2026 |
| RBC Capital | Daniel Perlin | $65 | $52.14 | +36.5% | Aug 7, 2026 |
| Barclays | Analyst unavailable | $52 | $54.11 | +9.2% | Aug 7, 2026 |
| Truist Financial | Analyst unavailable | $52 | $49.97 | +9.2% | Jul 24, 2026 |
| BMO Capital | Andrew Bauch | $55 | $50.92 | +15.5% | Jul 22, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $53 | $50.61 | +11.3% | Jul 22, 2026 |
| Goldman Sachs | Will Nance | $60 | $50.6 | +26.0% | Jul 9, 2026 |
| Wells Fargo | Analyst unavailable | $56 | $50.6 | +17.6% | Jul 9, 2026 |
| Barclays | Nik Cremo | $58 | $52.71 | +21.8% | Jul 8, 2026 |
| BNP Paribas | Thomas Poutrieux | $46 | $56.23 | -3.4% | Jun 5, 2026 |
| Truist Financial | Matthew Coad | $58 | $57.02 | +21.8% | May 29, 2026 |
| Morgan Stanley | Analyst unavailable | $65 | $56.05 | +36.5% | May 29, 2026 |
| BMO Capital | Analyst unavailable | $60 | $53.46 | +26.0% | May 15, 2026 |
| UBS | Analyst unavailable | $65 | $55.79 | +36.5% | May 6, 2026 |
| RBC Capital | Analyst unavailable | $75 | $56.68 | +57.5% | May 6, 2026 |
| Mizuho Securities | Analyst unavailable | $90 | $57.28 | +89.0% | May 6, 2026 |
| Robert W. Baird | Analyst unavailable | $78 | $57.28 | +63.8% | May 6, 2026 |
| Susquehanna | James Friedman | $91 | $62.14 | +91.1% | May 4, 2026 |
| Truist Financial | Analyst unavailable | $64 | $60.8 | +34.4% | Apr 24, 2026 |
| BMO Capital | Analyst unavailable | $65 | $63.26 | +36.5% | Apr 21, 2026 |
| Wells Fargo | Analyst unavailable | $62 | $53.9 | +30.2% | Mar 27, 2026 |
| Morgan Stanley | James Faucette | $64 | $62.85 | +34.4% | Feb 11, 2026 |
| UBS | Analyst unavailable | $70 | $62.92 | +47.0% | Feb 11, 2026 |
| Stephens | Charles Nabhan | $70 | $62.59 | +47.0% | Feb 11, 2026 |
| Cantor Fitzgerald | Ramsey El-Assal | $70 | $67.15 | +47.0% | Jan 26, 2026 |
| Stephens | Analyst unavailable | $75 | $66.46 | +57.5% | Jan 16, 2026 |
| Tigress Financial | Ivan Feinseth | $95 | $67.38 | +99.5% | Dec 31, 2025 |
| Mizuho Securities | Analyst unavailable | $100 | $67.94 | +110.0% | Dec 22, 2025 |
| Susquehanna | James Friedman | $99 | $64.26 | +107.9% | Nov 12, 2025 |
| Susquehanna | James Friedman | $99 | $63.8 | +107.9% | Nov 12, 2025 |
| BNP Paribas | Tom Poutrieux | $62 | $64.45 | +30.2% | Nov 5, 2025 |
| RBC Capital | Analyst unavailable | $85 | $68.29 | +78.5% | Oct 30, 2025 |
| UBS | Timothy Chiodo | $75 | $68.29 | +57.5% | Oct 30, 2025 |
| Oppenheimer | Rayna Kumar | $91 | $67.31 | +91.1% | Oct 30, 2025 |
| Stephens | Analyst unavailable | $80 | $70.6 | +68.0% | Oct 30, 2025 |
| Bernstein | Analyst unavailable | $80 | $70.6 | +68.0% | Oct 30, 2025 |
| Mizuho Securities | Analyst unavailable | $110 | $70.6 | +131.0% | Oct 30, 2025 |
| Morgan Stanley | James Faucette | $81 | $70.6 | +70.1% | Oct 30, 2025 |
| Goldman Sachs | Analyst unavailable | $79 | $70.6 | +65.9% | Oct 30, 2025 |
| Compass Point | Dominick Gabriele | $127.5 | $74.3 | +167.8% | Oct 29, 2025 |
| Mizuho Securities | Analyst unavailable | $145 | $127.83 | +204.5% | Oct 28, 2025 |
| Truist Financial | Analyst unavailable | $143 | $123.96 | +200.3% | Oct 24, 2025 |
| KeyBanc | Analyst unavailable | $145 | $126.07 | +204.5% | Oct 22, 2025 |
| Wells Fargo | Analyst unavailable | $130 | $126.07 | +173.0% | Oct 21, 2025 |
| BTIG | Analyst unavailable | $180 | $118 | +278.0% | Oct 17, 2025 |
| Deutsche Bank | Analyst unavailable | $122 | $121 | +156.2% | Oct 16, 2025 |
| Raymond James | Analyst unavailable | $167 | $125.96 | +250.7% | Oct 10, 2025 |
| Barclays | Ramsey El-Assal | $175 | $142.03 | +267.5% | Jul 28, 2025 |
| Morgan Stanley | Analyst unavailable | $500 | $172.33 | +950.1% | Jun 29, 2025 |
| Mizuho Securities | Dan Dolev | $200 | $159.13 | +320.0% | May 15, 2025 |
| RBC Capital | Analyst unavailable | $237 | $177.53 | +397.7% | Apr 25, 2025 |
| Morgan Stanley | Analyst unavailable | $268 | $177.53 | +462.9% | Apr 25, 2025 |
| UBS | Timothy Chiodo | $255 | $179.42 | +435.5% | Apr 25, 2025 |
| Piper Sandler | Analyst unavailable | $218 | $177.53 | +357.8% | Apr 25, 2025 |
| Seaport Global | Jeff Cantwell | $240 | $203.82 | +404.0% | Jan 14, 2025 |
| Stephens | Charles Nabhan | $255 | $201.76 | +435.5% | Dec 18, 2024 |
| Tigress Financial | Ivan Feinseth | $244 | $201.98 | +412.4% | Oct 29, 2024 |
| Mizuho Securities | Dan Dolev | $222 | $202.36 | +366.2% | Oct 24, 2024 |
| Argus Research | Stephen Biggar | $223 | $202.18 | +368.3% | Oct 23, 2024 |
| KeyBanc | Alex Markgraff | $225 | $199.67 | +372.5% | Oct 23, 2024 |
| RBC Capital | Kurt Hallead | $224 | $199.67 | +370.4% | Oct 23, 2024 |
| Wells Fargo | Andrew Bauch | $220 | $199.67 | +362.0% | Oct 23, 2024 |
| Williams Trading | Trevor Williams | $200 | $199.67 | +320.0% | Oct 22, 2024 |
| CFRA | Caydee Blankenship | $235 | $199.67 | +393.5% | Oct 22, 2024 |
| BTIG | Andrew Harte | $215 | $198.28 | +351.5% | Oct 22, 2024 |
| Williams Trading | Trevor Williams | $195 | $194.02 | +309.5% | Oct 16, 2024 |
| Morgan Stanley | James Faucette | $220 | $193.23 | +362.0% | Oct 15, 2024 |
| Bernstein | Harshita Rawat | $244 | $190.35 | +412.4% | Oct 14, 2024 |
| BMO Capital | Rufus Hone | $191 | $181.31 | +301.1% | Oct 1, 2024 |
| Citigroup | Ashwin Shirvaikar | $187 | $181.58 | +292.7% | Oct 1, 2024 |
| Oppenheimer | Rayna Kumar | $203 | $179.65 | +326.3% | Sep 30, 2024 |
| Robert W. Baird | David Koning | $200 | $177.61 | +320.0% | Sep 23, 2024 |
| BTIG | Andrew Harte | $200 | $170.17 | +320.0% | Aug 28, 2024 |
| Tigress Financial | Ivan Feinseth | $190 | $157.34 | +299.0% | Aug 6, 2024 |
| Mizuho Securities | Dan Dolev | $183 | $162.71 | +284.3% | Jul 30, 2024 |
| Deutsche Bank | Bryan Keane | $200 | $162.03 | +320.0% | Jul 25, 2024 |
| RBC Capital | Daniel Perlin | $183 | $161.16 | +284.3% | Jul 25, 2024 |
| B.Riley Financial | Hal Goetsch | $185 | $156.15 | +288.5% | Jul 25, 2024 |
| Argus Research | Stephen Biggar | $187 | $156.15 | +292.7% | Jul 25, 2024 |
| KeyBanc | Alex Markgraff | $180 | $161.16 | +278.0% | Jul 25, 2024 |
| Wells Fargo | Andrew Bauch | $190 | $161.16 | +299.0% | Jul 25, 2024 |
| Morgan Stanley | James Faucette | $175 | $114.23 | +267.5% | Jul 22, 2024 |
| Wells Fargo | Andrew Bauch | $180 | $148 | +278.0% | Jun 12, 2024 |
| Williams Trading | Trevor Williams | $160 | $156.78 | +236.0% | Mar 25, 2024 |
| Oppenheimer | Dominick Gabriele | $168 | $154.31 | +252.8% | Mar 19, 2024 |
| BNP Paribas | Tom Poutrieux | $156 | $135.4 | +227.6% | Jan 10, 2024 |
| KeyBanc | Alex Markgraff | $160 | $135.02 | +236.0% | Jan 8, 2024 |
| Wells Fargo | Analyst unavailable | $104 | $115.31 | +118.4% | Feb 8, 2023 |
| Credit Suisse | Analyst unavailable | $130 | $115.59 | +173.0% | Feb 8, 2023 |
| Susquehanna | Analyst unavailable | $140 | $115.48 | +194.0% | Feb 8, 2023 |
| Barclays | Analyst unavailable | $140 | $115.28 | +194.0% | Feb 8, 2023 |
| Raymond James | Analyst unavailable | $135 | $115.28 | +183.5% | Feb 8, 2023 |
| Wells Fargo | Analyst unavailable | $101 | $101.51 | +112.1% | Jan 9, 2023 |
| Goldman Sachs | Analyst unavailable | $105 | $100.73 | +120.5% | Jan 9, 2023 |
| Wells Fargo | Analyst unavailable | $107 | $105.75 | +124.7% | Sep 8, 2022 |
| Evercore ISI | David Togut | $149 | $108.11 | +212.9% | Aug 11, 2022 |
| Mizuho Securities | Dan Dolev | $145 | $106.08 | +204.5% | Aug 8, 2022 |
| Morgan Stanley | Analyst unavailable | $106 | $103.44 | +122.6% | Jul 27, 2022 |
| Wells Fargo | Jeff Cantwell | $97 | $91.72 | +103.7% | Jul 14, 2022 |
| Loop Capital Markets | Analyst unavailable | $125 | $99.5 | +162.5% | May 3, 2022 |
| Citigroup | Analyst unavailable | $122 | $102.18 | +156.2% | Apr 28, 2022 |
| Robert W. Baird | David Koning | $144 | $103.02 | +202.4% | Apr 20, 2022 |
| Citigroup | Ashwin Shirvaikar | $126 | $99.97 | +164.6% | Jan 26, 2022 |
| Mizuho Securities | Dan Dolev | $155 | $101.04 | +225.5% | Jan 25, 2022 |
| Tigress Financial | Ivan Feinseth | $150 | $109.11 | +215.0% | Jan 14, 2022 |
| Jefferies | Trevor Williams | $115 | $108.5 | +141.5% | Jan 12, 2022 |
| Wedbush | Moshe Katri | $130 | $100.52 | +173.0% | Dec 20, 2021 |
| Bank of America Securities | Jason Kupferberg | $139 | $103.65 | +191.9% | Dec 17, 2021 |
| Susquehanna | James Friedman | $135 | $104.23 | +183.5% | Dec 14, 2021 |
| UBS | Rayna Kumar | $108 | $100.88 | +126.8% | Nov 17, 2021 |
| Barclays | Ramsey El Assal | $128 | $98.49 | +168.8% | Oct 29, 2021 |
| Wolfe Research | Darrin Peller | $140 | $98.53 | +194.0% | Oct 28, 2021 |
Track every rating change on FISV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationFiserv, Inc. is a global provider of technology solutions for payments and financial services. Its operations are structured into three primary segments: Acceptance, Fintech, and Payments. The Acceptance segment enables businesses to process transactions at the point of sale and through digital channels, offering mobile payment capabilities and robust security and fraud prevention tools. Key offerings include Carat, its omnichannel commerce platform; Clover, a cloud-native platform for point-of-sale and business management; and Clover Connect, designed for independent software vendors. This segment reaches clients via diverse distribution channels, including direct sales, agent networks, ISVs, and financial institution partnerships.…
Historical context
All FISV earningsTechnology peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| WIT Wipro Limited | FY2027 Q2 · Calendar Q4 2026 | -25.0% | +3.9% | Wipro: AI pipeline expands as Q3 guidance stays narrow |
| TSM Taiwan Semiconductor Manufacturing Company Limited | FY2026 Q3 · Calendar Q4 2026 | +3.4% | -1.8% | TSMC beats Q3 guidance as AI demand drives fab expansion |
| ERIC Telefonaktiebolaget LM Ericsson (publ) | FY2026 Q3 · Calendar Q4 2026 | +28.6% | +11.8% | Ericsson Q3: 7% organic growth, resilient margins and AI-led demand |
| ASML ASML Holding N.V. | FY2026 Q3 · Calendar Q4 2026 | +20.4% | -3.9% | ASML: Record Q3, strong AI demand and broader capacity plans |
Latest beats and misses
Who reports nextBeat on EPS
Get the FISV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-16T13:10:42.256528+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-16. For educational purposes only; not investment advice.